About fundamental and clinical aspects of magnesium and ribolavine synergic action in therapeutic practice


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Article consequentially reflects the themes concerning the basis of magnesium and riboflavine pharmacology, prevalence of magnesium and riboflavine deficiencies, perspectives of combined magnesium-and riboflavine-based medicaments use for cardiovascular therapy, diseases with antiinflammatory component, metabolic disorders and migraine.

Texto integral

Acesso é fechado

Sobre autores

Olga Gromova

Federal research center «Informatics and management» of RAS; Federal State Budgetary Educational Institution of Higher Education «Ivanovo State Medical Academy» of the Ministry of Healthcare of the Russian Federation

Email: unesco.gromova@gmail.com
MD, professor, leading scientific worker, head of the pharmacoinformatics laboratory of “Informatics and management"; рrofessor of the Department of Pharmacology

Ivan Torshin

Federal research center «Informatics and management» of RAS

Email: tyu@yahoo.com
cand. of physical and mathematical sciences, senior scientific worker of “Informatics and management"

Zhanna Kobalava

Peoples' friendship university of Russia

MD, professor, head of the general medicine Department with cardiology and functional diagnostics course, head of the department of general medicine, cardiology and clinical pharmacology of the medical staff advanced training faculty

Maria Sorokina

Lomonosov Moscow state university

Email: info@fbm.msu.ru
medical resident of the general medicine Department of fundamental medicine faculty

Bibliografia

  1. Громова О.А., Калачева А.Г., Торшин И.Ю., Рудаков К.В., Грустливая У.Е., Юдина Н.В., Егорова Е.Ю., Лиманова О.А., Федотова Л.Э., Грачева О.Н., Никифорова Н.В., Сатарина Т.Е., Гоголева И.В., Гришина Т.Р., Курамшина Д.Б., Новикова Л.Б., Лисицына Е.Ю., Керимкулова Н.В., Владимирова И.С., Чекмарева М.Н., Лялякина Е.В., Шалаева Л.А., Талепоровская С.Ю., Силинг Т.Б., Прозорова Н.В., Семенов В.А., Семенова О.В., Назарова Н.А., Галустян А.Н., Сардарян И.С. Недостаточность магния - достоверный фактор риска коморбидных состояний: результаты крупномасштабного скрининга магниевого статуса в регионах России. Фарматека. 2013;6:114-29
  2. Jiang L., He P., Chen J., Liu Y., Liu D., Qin G., Tan N. Magnesium Levels in Drinking Water and Coronary Heart Disease Mortality Risk: A Meta-Analysis. Nutrients. 2016;8(1):5. doi: 10.3390/nu8010005 PMCID: PMC4728619
  3. Rapant S., Cveckova V., Fajcikova K., Dietzova Z., Stehlikova B. Chemical composition of groundwater/drinking water and oncological disease mortality in Slovak Republic. Environ. Geochem. Health. 2017;39(1):191-208. doi: 10.1007/s10653-016-9820-6
  4. Громова О.А., Торшин И.Ю. Магний и «болезни цивилизации». М., ГэотарМед, 2018. 800 с. ISBN 978-5-9704-4527-3. [Gromova O.A., Torshin I.Ju. Magnesium and «diseases of civilization». M. GastarMed, 2018. 800p. ISBN 978-5-9704-4527-3]
  5. Shlezinger M., Amitai Y., Goldenberg I., Shechter M. Desalinated seawater supply and all-cause mortality in hospitalized acute myocardial infarction patients from the Acute Coronary Syndrome Israeli Survey 2002-2013. Int. J. Cardiol. 2016; 220:544-50.
  6. Du W., Wang H., Chen S., Su C., Zhang H., Zhang B. [Trend of dietary nutrient intake among adult females in 9 provinces in China, 2000-201 1]. Zhonghua Liu Xing Bing Xue Za Zhi. 2015;36(7):715-9.
  7. Touvier M., Lioret S., Vanrullen I., Bocle J.C., Boutron-Ruault M.C., Berta J.L., Volatier J.L. Vitamin and mineral inadequacy in the French population: estimation and application for the optimization of food fortification. Int. J. Vitam. Nutr. Res. 2006;76(6):343-51.
  8. Martinez Tome M.J., Rodriguez A., Jimenez A.M., Mariscal M., Murcia M.A., Garcia-Diz L. Food habits and nutritional status of elderly people living in a Spanish Mediterranean city. Nutr. Hosp. 2011;26(5):1 175-82.
  9. Vaquero M.P., Sanchez-Muniz F.J., Carbajal A., Garcia-Linares M.C., Garcia-Fernandez M.C., Garcia-Arias M.T. Mineral and vitamin status in elderly persons from Northwest Spain consuming an Atlantic variant of the Mediterranean diet. Ann. Nutr. Metab. 2004;48(3):125-33.
  10. Maraver F., Vitoria I., Ferreira-Pêgo C., Armijo F., Salas-Salvado J. Magnesium in tap and bottled mineral water in Spain and its contribution to nutritional recommendations. Nutr. Hosp. 2015;31(5):2297-312. doi: 10.3305/nh.2015.31.5.8589
  11. Андреев А.В., Громова О.А., Федотова Л.Э., Бурцев Е.М. Влияние лактата магния на цереброваскулярную реактивность у детей с синдромом дефицита внимания в зависимости от содержания магния в организме, Клиническая фармакология и терапия. 2000;5:31-4.
  12. McCormick D.B. A trail of research on cofactors: an odyssey with friends. J. Nutr. 2000;130(2S Suppl):323-30S.
  13. Masui T., Staple E. The formation of bile acids from cholesterol. The conversion of 5-beta-cholestane-3-alpha,7-alpha-triol-26-oic acid to cholic acid via 5-beta-cholestane-3-alpha,7-alpha,12-alpha, 24-xi-tetraol-26-oic acid I by rat liver. J. Biol. Chem. 1966;241(17):3889-93.
  14. Robitaille J., Carmichael S.L., Shaw G.M., Olney R.S. Maternal nutrient intake and risks for transverse and longitudinal limb deficiencies: data from the National Birth Defects Prevention Study, 1997-2003. Birth Defects Res. A. Clin. Mol. Teratol. 2009;85(9):773-9.
  15. Thakur K., Tomar S.K., Singh A.K., Mandal S., Arora S. Riboflavin and health: A review of recent human research. Crit. Rev. Food Sci. Nutr. 2016;57(17):3650-60.
  16. Liu Y., Yu Q.Y., Zhu Z.L., Tang P.Y., Li K. Vitamin B2 intake and the risk of colorectal cancer: a meta-analysis of observational studies. Asian Pac. J. Cancer Prev. 2015;16(3):909-13.
  17. Murakami K., Miyake Y., Sasaki S., Tanaka K., Arakawa M. Dietary folate, riboflavin, vitamin B-6, and vitamin B-12 and depressive symptoms in early adolescence: the Ryukyus Child Health Study. Psychosom. Med. 2010;72(8):763-8.
  18. Mastropasqua L. Collagen cross-linking: when and how? Eye Vis. 2015;2:19. doi: 10.1186/s40662-01 5-0030-6
  19. Zempleni J., Galloway J.R., McCormick D.B. Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am. J. Clin. Nutr. 1996;63:52-66.
  20. Hajjar I., Kotchen T. Regional variations of blood pressure in the United States are associated with regional variations in dietary intakes: the NHANES-III data. J. Nutr. 2003;133(1):211-4.
  21. Stamler J., Elliott P., Appel L., Chan Q., Buzzard M., Dennis B., Dyer A.R., Elmer P., Greenland P., Jones D., Kesteloot H., Kuller L., Labarthe D., Liu K., Moag-Stahlberg A., Nichaman M., Okayama A., Okuda N., Robertson C., Rodriguez B., Stevens M., Ueshima H., Horn L.V., Zhou B. Higher blood pressure in middle-aged American adults with less education-role of multiple dietary factors: the INTERMAP study. J. Hum. Hypertens. 2003;17(9):655-775.
  22. Dyer A.R., Elliott P., Stamler J., Chan Q., Ueshima H., Zhou B.F. Dietary intake in male and female smokers, ex-smokers, and never smokers: the INTERMAP study. J. Hum. Hypertens. 2003;17(9):641-54.
  23. McKeag N.A., McKinley M.C., Harbinson M.T., McGinty A., Neville C.E., Woodside J.V., McKeown P.P. Dietary Micronutrient Intake and Micronutrient Status in Patients With Chronic Stable Heart Failure: An Observational Study. J. Cardiovasc. Nurs. 2016;32(2):148-55.
  24. Witte K.K., Nikitin N.P., Parker A.C., von Haehling S., Volk H.D., Anker S.D., Clark A.L., Cleland J.G. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur. Heart J. 2005;26(21):2238-44. Epub 2005 Aug 4.
  25. Bhardwaj P., Thareja S., Prakash S., Saraya A. Micronutrient antioxidant intake in patients with chronic pancreatitis. Trop. Gastroenterol. 2004;25(2):69-72.
  26. Geerling B.J., Badart-Smook A., Stockbrugger R.W., Brummer RJ. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur. J. Clin. Nutr. 2000;54(6):514-21.
  27. van Rensburg S.J., Hall J.M., Gathercole P.S. Inhibition of esophageal carcinogenesis in corn-fed rats by riboflavin, nicotinic acid, selenium, molybdenum, zinc, and magnesium. Nutr. Cancer. 1986;8(3):163-70.
  28. Jiang L., Sun C., Zhou X., Wang H., Ren L. [Effect of dietary mineral nutrients and vitamins on metabolism of rat fed with high fat]. Wei Sheng Yan Jiu. 2004;33(4):447-9.
  29. Norat T., Dossus L., Rinaldi S., Overvad K., Gronbaek H., Tjonneland A., Olsen A., Clavel-Chapelon F., Boutron-Ruault M.C., Boeing H., Lahmann P.H., Linseisen J., Nagel G., Trichopoulou A., Trichopoulos D., Kalapothaki V., Sieri S., Palli D., Panico S., Tumino R., Sacerdote C., Bueno-de-Mesquita HB., Peeters P.H., van Gils C.H., Agudo A., Amiano P., Ardanoz E., Martinez C., Quiros R., Tormo M.J., Bingham S., Key T.J., Allen N.E., Ferrari P., Slimani N., Riboli E., Kaaks R. Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur. J. Clin. Nutr. 2007;61(1):91-8. Epub 2006 Aug 9.
  30. Bonnefont-Rousselot D. The role of antioxidant micronutrients in the prevention of diabetic complications. Treat. Endocrinol. 2004;3(1):41-52.
  31. da Cunha A.T., Pereira H.T., de Aquino S.L., Sales C.H., Sena-Evangelista K.C., Lima J.G., Lima S.C., Pedrosa L.F. Inadequacies in the habitual nutrient intakes of patients with metabolic syndrome: a cross-sectional study. Diabetol. Metab. Syndr. 2016;8:32.
  32. Majewski M., Kozlowska A., Thoene M., Lepiarczyk E., Grzegorzewski W.J. Overview of the role of vitamins and minerals on the kynurenine pathway in health and disease. J. Physiol. Pharmacol. 2016;67(1):3-19.
  33. Mari-Bauset S., Llopis-Gonzalez A., Zazpe I., Mari-Sanchis A., Morales Suarez-Varela M. Comparison of nutritional status between children with autism spectrum disorder and typically developing children in the Mediterranean Region (Valencia, Spain). Autism. 2016;21(3):310-22.
  34. Kaluzna-Czaplinska J., Socha E., Rynkowski J. B vitamin supplementation reduces excretion of urinary dicarboxylic acids in autistic children. Nutr. Res. 2011;31(7):497-502.
  35. Sandor P.S., Afra J. Nonpharmacologic treatment of migraine. Curr. Pain Headache Rep. 2005;9(3):202-5.
  36. Rajapakse T., Pringsheim T. Nutraceuticals in Migraine: A Summary of Existing Guidelines for Use. Headache. 2016;56(4):808-16.
  37. Bianchi A., Salomone S., Caraci F., Pizza V., Bernardini R., D'Amato C.C. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis. Vitam. Horm. 2004;69:297-312.
  38. Taylor F.R. Nutraceuticals and headache: the biological basis. Headache. 2011;51(3):484-501.
  39. Turlapaty P.D., Altura B.M. Magnesium deficiency produces spasms of coronary arteries: Relationship to etiology of sudden death ischemic heart disease. Science. 1980;208:198-200.
  40. Altura B.T., Altura B.M. Withdrawal of magnesium causes vasospasm while elevated magnesium produces relaxation of tone incerebral arteries. Neurosci Lett. 1980;20:323-7.
  41. Altura B.M., Turlapaty P.D. Withdrawal of magnesium enhances coronary arterial spasms produced by vasoactive agents. Br. J. Pharmacol. 1982;77:649-59.
  42. Weglicki W.B., Chmielinska J.J., Tejero-Taldo I., Kramer J.H., Spurney C.F., Viswalingham K., Lu B., Mak I.T. Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia. Magnes Res. 2009;22(3):167-73S.
  43. Scher A.I. Comment on Rubino et al. "Association of the C677T polymorphism in the MTHFR gene with migraine: A metaanalysis." Cephalalgia. 2009;29:807-8.
  44. McNulty H., Pentieva K., Hoey L., Ward M. Homocysteine, B-vitamins and CVD. Proc. Nutr. Soc. 2008;67:232-7.
  45. Welch K.M., Ramadan N.M. Mitochondria, magnesium and migraine. J. Neurol. Sci. 1996;134:9-14.
  46. Gaul C., Diener H.C., Danesch U. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J. Headache Pain. 2015;16:516.
  47. Caudarella R., Vescini F., Buffa A., Stefoni S. Citrate and mineral metabolism: kidney stones and bone disease. Front. Biosci. 2003;8:s1084-106.
  48. Pak C.Y. Medical prevention of renal stone disease. Nephron. 1999;81(Suppl 1):60-5.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies